Outstanding Scholarly Physician Award
Bryan Haugen, MD
Haugen is a professor of medicine and pathology at the University of Colorado School of Medicine in Aurora, Colo., and a recognized leader in the evaluation and management of thyroid cancer. He played a key role in studies that showed the effectiveness of recombinant human thyroid‐stimulating hormone as a tool for monitoring patients with thyroid cancer. He also was instrumental in developing a novel Gene Expression Classifier diagnostic panel that significantly enhances the accuracy of diagnosing thyroid cancer.
He has written and lectured extensively to clinicians worldwide on the use of molecular diagnostic testing in the evaluation of thyroid nodules. He oversaw the development of the 2015 American Thyroid Association Guidelines for the Management of Thyroid Nodules and Differentiated Thyroid Cancer. These guidelines are now used by virtually every clinical endocrinologist in the U.S. in the day-to-day management of thyroid cancer.
How has the Endocrine Society supported your professional development/career journey?
For me, the Endocrine Society has been a tremendous organization for clinical and scientific networking. My professional development has been supported through connections with colleagues and friends, new collaborations, and the Endocrine Society’s tremendous support for our trainees.
As a Laureate Award recipient, do you have any advice for those just beginning their careers?
I would recommend following your curiosity and passion. The other things will fall into place. I really like the quote from Frederick Beuchner, “You find your vocation at the spot where your deepest gladness meets the world’s deepest need.”
About the Award
The Outstanding Scholarly Physician Award is presented in recognition of outstanding contributions to the practice of clinical endocrinology in an academic setting. Sponsored by the Endocrine Society.
Loading ...